Unapproved process parameter change during tech transfer – FDA inspection observation breakdown


Published on 05/01/2026

Further reading: Manufacturing Deviation Case Studies

Breakdown of FDA Inspection Observations Related to Unapproved Process Parameter Changes During Tech Transfer

In the pharmaceutical manufacturing environment, process integrity is essential to ensure compliance with Good Manufacturing Practices (GMP). A recent case study illustrates the consequences of unapproved process parameter changes during a tech transfer that led to FDA inspection observations. This article will delve into the scenario’s specific details, investigating the failure modes, containment strategies, and the corrective action and preventive action (CAPA) plan. By the end of this article, readers will understand how to navigate similar situations and enhance inspection readiness.

If you want a complete overview with practical prevention steps, see this Manufacturing Deviation Case Studies.

This case study details a real-world scenario where a deviation due to unapproved process parameter changes was not only identified but also investigated, resulting in structured corrective measures. The insights gained will help pharmaceutical professionals solidify their frameworks for deviation investigation

and ensure compliance with regulatory expectations.

Symptoms/Signals on the Floor or in the Lab

The unapproved process parameter change during a tech transfer can manifest in several symptoms, both in manufacturing operations and laboratory settings. For instance:

  • Increased variability in product quality: Batch records showed inconsistent potency levels across multiple batch runs.
  • Unanticipated equipment stress: Vibration monitoring conducted on mixers indicated abnormal operational ranges.
  • Non-conformance reports (NCRs): An uptick in NCRs linked to specific batches, particularly when changes in viscosity and blending time had not been formally documented.

In this case, cross-functional teams raised flags during routine quality checks, correlating these symptoms with potential deviations originating from altered process parameters.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the probable causes of the observed symptoms requires a systematic categorization of failure modes. Here’s a breakdown based on common categories:

Category Likely Causes
Materials Variability in raw materials affecting final product characteristics, potentially due to unapproved supplier changes.
Method Inadvertent application of unapproved process parameters; for instance, modifying mixing times without validation.
Machine Equipment calibration status not aligning with modified processes, leading to failure to meet specified ranges.
Man Lack of training regarding new parameters resulting in improper execution of manufacturing processes.
Measurement Inaccurate or unvalidated measurement techniques resulting in misleading data for batch quality assessment.
Environment Uncontrolled conditions in the manufacturing environment, influencing the raw material behavior and subsequently the product outcomes.
Pharma Tip:  Unplanned hold time extension during inspection preparation – root cause analysis failure explained

Immediate Containment Actions (first 60 minutes)

When the unapproved process parameter change was identified, immediate containment was critical to mitigate further deviations. The following actions were executed:

  1. Halt Production: Immediately ceased the operation of affected lines to prevent the manufacture of additional non-compliant batches.
  2. Inspect Current Batches: Conducted a quick visual inspection of batches produced under the suspect parameters, identifying those that were at risk of quality issues.
  3. Notify Stakeholders: Relevant teams, including Quality Control (QC), Quality Assurance (QA), and Production Management were alerted to assess the incident’s severity and scope.
  4. Documentation Review: Promptly reviewed batch records and associated documentation to trace and verify the nature of the process parameter changes.

These immediate actions were essential for containing the issue before it escalated, ensuring that no further non-compliance was propagated through production.

Investigation Workflow (data to collect + how to interpret)

A structured investigation workflow is critical following a deviation incident. For the unapproved process parameter change scenario, the following data collection steps were implemented:

  • Gather Batch Records: Collect comprehensive batch records, including process parameter logs, equipment calibration data, and operators’ documentation.
  • Interview Staff: Engage personnel involved in the tech transfer and ongoing operations to gather insights on the parameter changes and their seniority levels.
  • Review Training Documentation: Analyze training records to confirm staff proficiency in the newly implemented process parameters and any gaps in knowledge.
  • Conduct Environmental Monitoring: Assess environmental data such as humidity and temperature to examine potential impact factors.

Data interpretation focused on isolating correlations between discrepancies in process control and the affected quality parameters. Statistical analyses were used to detect patterns indicative of the unapproved changes.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Root cause analysis is a vital part of the investigation following a deviation. Several tools can assist in understanding the underlying issues:

  • 5-Why Analysis: Effective for straightforward problems, this method involved asking “why” repeatedly (up to 5 times) to drill down to the root cause of the parameter change.
  • Fishbone Diagram: This tool visualized potential causes across categories (Materials, Method, Man, etc.) during team brainstorming sessions, pinpointing the multifaceted issues related to the deviation.
  • Fault Tree Analysis: Applied for complex situations with multiple interrelated causes; it helped to diagram the relationships between various failure modes and their effects on process integrity.
Pharma Tip:  Critical IPC skipped during routine manufacturing – CAPA ineffectiveness identified

Each tool has unique applicability; the selection depends on the complexity and scope of the deviation being analyzed. The combined use of 5-Why and Fishbone diagrams proved particularly effective in this case.

CAPA Strategy (correction, corrective action, preventive action)

The CAPA strategy developed from the investigation provided a structured approach to managing the unapproved process parameter change:

  • Correction: Immediate correction involved reverting to previously validated process parameters and post hoc testing to assess batch quality and safety.
  • Corrective Action: Conduct a comprehensive review of the tech transfer protocols and update them to ensure all process changes require formal approval before implementation.
  • Preventive Action: Implement regular refresher training for all relevant staff on process parameters and the significance of compliance with tech transfer protocols.

The documentation of each step, including meeting notes and training records, will provide critical evidence of the CAPA process in being compliant with regulatory expectations.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

To prevent recurrence of issues related to unapproved process parameter changes, a robust control strategy was initiated, including:

  • Statistical Process Control (SPC): Implement SPC tools to monitor process variability and product quality continuously, facilitating early detection of deviations.
  • Random Sampling: Establish a routine schedule for random sampling of both raw materials and finished products, ensuring consistency with quality specifications.
  • Alarms/Alerts: Set up alarms in the manufacturing equipment that trigger when parameters deviate beyond pre-defined control limits.
  • Routine Verification: Conduct routine audits of equipment and processes, validating adherence to approved parameters and identifying potential gaps.

This comprehensive approach ensures continual oversight of manufacturing quality and adherence to best practices in process control.

Related Reads

Validation / Re-qualification / Change Control impact (when needed)

Following the incident, the need for validation and re-qualification efforts became apparent:

  • Validation of Processes: Conduct a full validation of all processes impacted by the unapproved parameter changes, redefining validation protocols as necessary.
  • Re-qualification of Equipment: All equipment involved required re-qualification to ensure alignment with updated processes and validated operational parameters.
  • Change Control Updates: Revise change control procedures to enhance scrutiny over process modifications, ensuring complete documentation and approval are essential prior to implementation.

Comprehensive validation and change control measures help ensure future compliance and minimize risk.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

To ensure preparedness for potential regulatory inspections following the deviation, demonstrable evidence of compliance must be readily available:

  • Batch Records: Complete records documenting the manufacture of all sampled batches, including process parameters, quality checks, and deviations noted.
  • Deviation Reports: Well-documented deviation reports outlining investigation results, CAPA plans, and subsequent implementations.
  • Change Control Logs: Clear records showcasing all changes made to process parameters, including dates, reasons, and approval statuses, should be maintained.
  • Training Logs: Comprehensive training documentation for staff involved in manufacturing processes, including records demonstrating completion of retraining sessions related to tech transfer.
Pharma Tip:  Deviation recurrence across batches during tech transfer – root cause analysis failure explained

By compiling these records, companies can demonstrate their adherence to GMP standards during regulatory audits, thereby enhancing inspection readiness.

FAQs

What constitutes an unapproved process parameter change?

An unapproved process parameter change refers to modifications made to critical manufacturing parameters without adhering to formal change control procedures.

How to identify process deviations early?

Utilizing real-time monitoring and SPC tools can help identify inconsistencies in process parameters before they lead to significant deviations.

What are the main aspects of a CAPA plan?

A CAPA plan should consist of a correction, corrective action, and preventive action, ensuring that deviations are managed comprehensively.

How can I prepare for a regulatory inspection?

Preparation involves thorough documentation, complete records of deviations and CAPAs, and training logs of personnel involved in manufacturing processes.

What should be included in a deviation report?

A deviation report should detail the nature of the deviation, investigation findings, evidence of root cause analysis, and documented corrective actions.

What is the role of change control in pharma?

Change control serves to manage and document changes to processes, ensuring all modifications receive the necessary approvals before implementation to maintain compliance.

How do I train staff on new process parameters?

Training should involve formal sessions outlining the significance of approved parameters, operational impact, and procedural compliance, supplemented with evaluations to confirm understanding.

What is the importance of documentation in GMP compliance?

Documentation is critical for demonstrating compliance, traceability of processes, and providing evidence during regulatory inspections.

How can SPC contribute to quality assurance?

SPC contributes to quality assurance by monitoring process variations in real-time, allowing for timely interventions before non-conformities arise.

What are the implications of failing an inspection?

Failing an inspection can lead to regulatory penalties, product recalls, or discontinuation of manufacturing, impacting the organization’s reputation and financial stability.

What proactive measures can reduce deviations?

Implementing robust training, routine audits, and a structured change control process can help detect and reduce deviations proactively.

How do I conduct a systematic root cause analysis?

Use established root cause analysis tools such as 5-Why, Fishbone Analysis, or Fault Tree Analysis to systematically identify the underlying issues of deviations.